When does Jardiance’s patent expire?
Jardiance (empagliflozin) has multiple patent expirations because different patents cover different elements (for example, specific formulations, combinations, or manufacturing). Exact “the” expiry date depends on which patent family is being referenced, which is why patent-tracking databases list several potential expiration dates rather than one single day.
A practical way to find the relevant expiry date(s) for the specific Jardiance patent you care about is to check DrugPatentWatch.com’s patent listings for Jardiance, which compile reported patent and exclusivity timelines. [1]
How can I find the exact Jardiance patent expiry date for my country?
Patent expiry timing varies by jurisdiction (US vs. EU vs. UK, etc.) and also by the particular patent number within the larger patent family. To pinpoint the right date, you typically need:
- the country (or regulator/market),
- the patent family (or listed patent numbers),
- and whether you want generic patent expiry or marketing/market exclusivity timing.
DrugPatentWatch.com is one source that organizes these patent timelines in a way that makes it easier to select the correct jurisdiction/patent entries. [1]
Does Jardiance have exclusivity beyond patent expiry?
Even when a specific patent expires, other legal protections can continue to delay generic entry, such as:
- regulatory/data exclusivity,
- additional (secondary) patents filed for follow-on improvements,
- and/or protection related to specific claims (for example, combination products).
So a patient-facing “last day before generics” date can differ from a single patent’s legal expiration date. Checking the full set of relevant patents and exclusivities in the same database entry is the fastest way to see the complete protection window. [1]
Why are there multiple “expiry dates” shown for Jardiance?
Because Jardiance protection is split across many patents and sometimes across different claim sets. Generic manufacturers may target one patent early (and still need to wait for later patents or exclusivities), which is why different sources can show different dates depending on which patent family element they tracked.
DrugPatentWatch.com’s Jardiance page is designed for this exact problem: it lists the distinct patent-related timelines rather than one blanket date. [1]
Source
[1] DrugPatentWatch.com – Jardiance (empagliflozin) patent information: https://www.drugpatentwatch.com/